Case Studies

Sponsor Shifts From Faltering Large CRO to PRC Clinical

Challenge > DELAYED DELIVERABLES AND EXCESSIVE TURNOVER A neurodegenerative sponsor based in the United States evaluated PRC Clinical to provide clinical support for their Phase I Alzheimer’s study. By direction […]

December 15, 2016

Support of Israeli Sponsor to Transition to the US Market

Background > Israel-Based Stem Cell-Focused Sponsor Selects PRC Clinical for Us Trial PRC Clinical was contracted by an Israeli-based stem cell-focused sponsor to help them transition to the US market. […]

March 10, 2015

Successful CRO Audits to Recover Critical Data

Challenge > Short Timeline to Recover Data After Terminated CRO Contract PRC Clinical was contacted by a US-based sponsor to help them recover critical study data from their previous CRO after […]

March 10, 2015

Enrollment Improved for Phase III Clinical Study

Background > Sponsor Partners With PRC Clinical On Phase III Cardiac Study PRC Clinical supported a biopharmaceutical company headquartered in Palo Alto (CA) to accelerate poor enrollment for two large phase III […]

March 10, 2015

FPI Before Year-end for US-Based Phase II Study

Background > Clinical Site Management and Monitoring for Local Sponsor PRC Clinical was contracted as the CRO for a Silicon Valley based sponsor for a clinical site management and site monitoring project. The […]

March 10, 2015

PRC Clinical Supports Australian Pharma to Run US Study

BACKGROUND > PRC CLINICAL AWARDED FULL-SERVICE PROJECT TO SUPPORT AUSTRALIAN PHARMA COMPANY PRC Clinical provided full-service CRO support to Xenome, Brisbane-based Australian biotech company. Xenome initiated a Phase I clinical trial […]

March 10, 2015

Experienced Team Meets Accelerated Timeline in Global Phase 2B Study

BACKGROUND > PRC CLINICAL CHOSEN FOR GLOBAL PHASE 2 TRIAL OVERSIGHT, SITE MANAGEMENT AND MONITORING PRC Clinical was awarded a global phase II clinical trial by an ALS-focused biotechnology company based in South […]

March 10, 2015